Learn More
Apexbio Technology LLC AZD3839 1227163-56-5 10mg

Supplier: Apexbio Technology LLC B322410
AZD3839 (CAS 1227163-56-5) is a small-molecule inhibitor targeting BACE1 ( -site APP cleaving enzyme 1) It is designed to inhibit BACE1 thereby reducing amyloid (A ) peptide production implicated in Alzheimer s disease pathology AZD3839 exerts its biological activity primarily through inhibition of human BACE1 enzyme activity In cell-based studies AZD3839 demonstrates reduction of soluble amyloid precursor protein beta (sAPP ) and A 40 secretion in neuronal cellular models including human SH-SY5Y cells mouse neuroblastoma N2A cells and primary cortical neurons from mice and guinea pigs Based on these pharmacological properties AZD3839 holds research potential in Alzheimer s disease studies
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.